The Global Market for Clinical Nutrition Products is Projected to Reach US$52.7 Billion by 2022
Imperative Need to Support Critical
Nutritional Needs of Malnourished Patients, the Elderly and Infants to Spur
Growth in the Global Clinical Nutrition Products Market, According to a New
Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market share, size and demand forecasts on the global Clinical Nutrition
Products market. The global market for Clinical Nutrition Products is
projected to reach US$52.7 billion by 2022, driven by the growing need to provide nutritional support to the
elderly and patients suffering from chronic medical conditions.
Clinical
nutrition is one of the most critical areas of medicine and patient healthcare
management. Clinical nutrition is vital for patients who are unable to consume
normal food, as nutritional deficiency caused by underlying disease condition
enhances the risk of complications, lengthens recovery period, lowers quality
of life, and increases the risk of mortality among such patients. Comprising
pharmaceutical-grade clinical foods and dietary supplements, clinical nutrition
products are delivered through parenteral or enteral feeding routes, as a means
to address issues such as eating disorders and metabolic disorders. Global
market for clinical nutrition products is being driven by the increasing
nutritional needs of an aging global population, rising incidence of chronic
and lifestyle-related diseases, growing number of malnourished patients,
increasing number of preterm births and the shift towards home care, all of
which are driving emphasis onto the treatment of malnutrition in patients. In
particular, the rising number of geriatric people with weak digestive systems
implies that chronic diseases and loss of appetite are common issues confronting
this age group, thus necessitating administration of clinical nutrition
solutions. Demand for enteral and parenteral nutrition is also emerging due to
the rapidly rising incidences of chronic and lifestyle-related diseases such as
cancer, diabetes, cardiovascular diseases, gastrointestinal disorders and
dementia across the world.
Infant nutrition products are used to assist development of infants, with the need for
nutritional support highest among preterm infants. Since preterm babies suffer
from immature organ development and lack of adequate immune response, they are
unable to consume nutrition normally and nutrition being provided is inadequate,
thus exposing the infants to higher risk of developing various health issues.
The demand for safe, high quality and nutritive products for meeting the
nutritional needs of premature infants, low-weight infants, and those afflicted
by some medicals conditions is expected to fuel growth in the infant nutrition
market over the coming years. Enteral nutrition products market continues to
benefit from the development of disease-specific nutrient formulations. A large
number of patients suffering from various medical conditions are given enteral
nutrition therapies, owing to the advantages offered in the form of
cost-effectiveness, safety and convenience of administration, and reduced
discomfort. Parenteral nutrition, on the other hand, is being influenced by the
adoption of stringent regulations, particularly in the U.S.
As
stated by the new market research report on Clinical Nutrition Products, the United States represents the largest market
worldwide. Rising cases of malnutrition among the elderly and those suffering
from some form of chronic illness are propelling demand for clinical nutrition
therapies. The market is also favored by the widespread availability of a broad
variety of clinical nutrition solutions, high level of awareness about its
benefits among patients and healthcare professionals and availability of reimbursement
coverage. Asia-Pacific is forecast to grow at the fastest CAGR of 9.2% over the
analysis period.
Major
players covered in the report include Abbott Nutrition, Baxter International
Inc., B. Braun Melsungen AG, Claris Lifesciences Ltd., Groupe Danone, Fresenius
Kabi AG, ICU Medical Inc., Mead Johnson Nutrition Company, Meiji Co. Ltd.,
Nestlé Health Science S.A, Otsuka Pharmaceutical Factory Inc. and Huarui
Pharmaceutical Co. Ltd., among others.
The
research report titled “Clinical Nutrition Products: A Global Strategic
Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market
estimates and projections for all major geographic markets such as the US,
Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of
Europe), Asia-Pacific (Australia, China, India and Rest of Asia-Pacific),
Middle East & Africa and Latin America (Brazil, Mexico and Rest of Latin
America). The market is analyzed by the following product segments - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition.
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose
CA 95138, USA, All Rights Reserved.
Comments
Post a Comment